| Rowatanal Cream PA0074/016/001 |
Bismuth subgallate, Zinc oxide, Menthol |
Rowa Pharmaceuticals Limited |
Marketed |
| Rowatinex Gastro-resistant Capsules, Soft PA0074/009/001 |
Beta pinene, Cineole, Camphene, Alpha pinene, Fenchone |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rowatinex Oral Drops, Solution PA0074/009/002 |
Anethol, Alpha pinene, Borneol, Fenchone, Camphene |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rozlytrek 100 mg hard capsules EU/1/20/1460/001 |
Entrectinib |
Roche Registration GmbH |
— |
| Rozlytrek 200 mg hard capsules EU/1/20/1460/002 |
Entrectinib |
Roche Registration GmbH |
— |
| Rozlytrek 50 mg film-coated granules in sachet EU/1/20/1460/003 |
Entrectinib |
Roche Registration GmbH |
— |
| Rubraca 200 mg Film-coated tablet EU/1/17/1250/001 |
Rucaparib camsylate |
pharmaand GmbH |
— |
| Rubraca 250 mg Film-coated tablet EU/1/17/1250/002 |
Rucaparib camsylate |
pharmaand GmbH |
— |
| Rubraca 300 mg Film-coated tablet EU/1/17/1250/003 |
Rucaparib camsylate |
pharmaand GmbH |
— |
| Ruconest 2100 Units powder and solvent for solution for injection EU/1/10/641/002 |
Conestat alfa |
Pharming Group N.V. |
— |
| Ruconest 2100 Units powder for solution for injection EU/1/10/641/001 |
Conestat alfa |
Pharming Group N.V. |
— |
| Rukobia 600 mg prolonged-release tablets EU/1/20/1518/001 |
Fostemsavir Tromethamine |
ViiV Healthcare BV |
— |
| Ruxience 100 mg concentrate for solution for infusion EU/1/20/1431/001 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| Ruxience 500 mg concentrate for solution for infusion EU/1/20/1431/002 |
Rituximab |
Pfizer Europe MA EEIG |
— |
| RXULTI 0.25 mg Film-coated tablet EU/1/18/1294/001 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| RXULTI 0.5 mg Film-coated tablet EU/1/18/1294/002 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| RXULTI 1 mg Film-coated tablet EU/1/18/1294/003-004 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| RXULTI 2 mg Film-coated tablet EU/1/18/1294/005 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| RXULTI 3 mg Film-coated tablet EU/1/18/1294/006 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| RXULTI 4 mg Film-coated tablet EU/1/18/1294/007 |
Brexpiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension PA1543/002/001 |
Mometasone furoate, Olopatadine |
Glenmark Pharmaceuticals s.r.o. |
Marketed |
| Rybelsus 1.5 mg tablets EU/1/20/1430/016-020 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 14 mg tablets EU/1/20/1430/008-010 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 25 mg tablets EU/1/20/1430/031-035 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 3 mg tablets EU/1/20/1430/001-004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 4 mg tablets EU/1/20/1430/021-025 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 50 mg tablets EU/1/20/1430/036-040 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 7 mg tablets EU/1/20/1430/005-007 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 9 mg tablets EU/1/20/1430/026-030 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybrevant 1 600 mg solution for injection EU/1/21/1594/002 |
Amivantamab |
Janssen-Cilag International NV |
— |
| Rybrevant 2240 mg solution for injection EU/1/21/1594/003 |
Amivantamab |
Janssen-Cilag International NV |
— |
| Rybrevant 350 mg concentrate for solution for infusion EU/1/21/1594/001 |
Amivantamab |
Janssen-Cilag International NV |
— |
| Rydapt 25 mg soft capsules EU/1/17/1218/001 |
Midostaurin |
Novartis Europharm Limited |
— |
| Ryeqo 40 mg/1 mg/0.5 mg film-coated tablets EU/1/21/1565/001-002 |
Relugolix, Estradiol hemihydrate, Norethisterone acetate |
Gedeon Richter Plc |
— |
| Ryjunea 0.1 mg/ml eye drops, solution EU/1/25/1920/001-002 |
Atropine sulfate |
Santen OY |
— |
| Rystiggo 140 mg/ml solution for injection EU/1/23/1780/001 |
Rozanolixizumab |
UCB Pharma S.A. |
— |
| Rytelo 188 mg powder for concentrate for solution for infusion EU/1/24/1894/002 |
Imetelstat sodium |
Geron Netherlands B.V. |
— |
| Rytelo 47 mg powder for concentrate for solution for infusion EU/1/24/1894/001 |
Imetelstat sodium |
Geron Netherlands B.V. |
— |
| Ryzneuta 20 mg solution for injection EU/1/24/1793/001 |
Efbemalenograstim alfa |
Evive Biotechnology Ireland Limited |
— |
| Ryzodeg 100 units/mL solution for injection EU/1/12/806/1,4,5,7,8 |
Insulin degludec (ideg), Insulin aspart |
Novo Nordisk A/S |
— |
| Salbutamol Neutec 2.5 mg/2.5 ml nebuliser solution PA23030/002/001 |
SALBUTAMOL SULFATE |
Neutec Inhaler Ireland Limited |
Not marketed |
| Salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection PA0869/008/001 |
Triptorelin |
Ipsen Pharmaceuticals Limited |
Not marketed |
| Samsca 15 mg Tablet EU/1/09/539/1-2 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Samsca 30 mg Tablet EU/1/09/539/3-4 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Samsca 7.5 mg Tablet EU/1/09/539/005-006 |
Tolvaptan (opc-41061) |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| SANCUSO 3.1 mg/24 hours transdermal patch EU/1/12/766/001 |
Granisetron |
Grünenthal GmbH |
— |
| Saphnelo 300 mg Concentrate for solution for infusion EU/1/21/1623/001 |
Anifrolumab |
AstraZeneca AB |
— |
| Sapropterin Dipharma 100 mg Soluble tablet EU/1/21/1620/001-003 |
Sapropterin hydrochloride |
Dipharma Arzneimittel GmbH |
— |
| Sapropterin Dipharma 500 mg Powder for oral solution EU/1/21/1620/004 |
Sapropterin hydrochloride |
Dipharma Arzneimittel GmbH |
— |
| SARCLISA 20 mg/mL concentrate for solution for infusion EU/1/20/1435/001-003 |
Isatuximab |
Sanofi Winthrop Industrie |
— |